Two Sigma Advisers’s Zynerba Pharmaceuticals, Inc ZYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $40.4K | Sell |
|
|||||
|
2023
Q1 | $62.3K | Sell |
|
|||||
|
2022
Q4 | $98.6K | Sell |
|
|||||
|
2022
Q3 | $145K | Buy |
|
|||||
|
2022
Q2 | $224K | Buy |
|
|||||
|
2022
Q1 | $290K | Buy |
|
|||||
|
2021
Q4 | $310K | Sell |
|
|||||
|
2021
Q3 | $743K | Buy |
|
|||||
|
2021
Q2 | $680K | Sell |
|
|||||
|
2021
Q1 | $781K | Buy |
|